EDIT (STOCKS)
Editas Medicine, Inc. Common Stock
$2.850000
+0.010000 (+0.35%)
Prev close: $2.840000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Gilmore O’Neill
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $463.32M
- Employees
- 226
- P/E (TTM)
- -3.81
- P/B (TTM)
- 4.14
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
8
Buy
4
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.15 | $-0.28 | +0.1253 | +45.51% |
|
Mar 2026 (Q1)
|
$-0.26 | $-0.27 | +0.0090 | +3.35% |
|
Dec 2025 (Q4)
|
$-0.06 | $-0.26 | +0.2033 | +77.21% |
|
Sep 2025 (Q3)
|
$-0.28 | $-0.30 | +0.0222 | +7.35% |
Financial Statements
| Revenues | $47.01M |
| Benefits Costs and Expenses | $0.00 |
| Costs And Expenses | $122.87M |
| Nonoperating Income/Loss | $1.91M |
| Operating Expenses | $122.87M |
| Research and Development | $84.96M |
| Other Operating Expenses | $37.91M |
| Operating Income/Loss | -$75.86M |
| Income/Loss From Continuing Operations After Tax | -$73.95M |
| Income/Loss From Continuing Operations Before Tax | $47.01M |
| Net Income/Loss | -$73.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$73.95M |
| Net Income/Loss Available To Common Stockholders, Basic | -$73.95M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.68 |
| Diluted Earnings Per Share | -$0.68 |
| Basic Average Shares | 201,604,117 |
| Diluted Average Shares | 201,604,117 |
| Assets | $237.36M |
| Current Assets | $218.07M |
| Accounts Receivable | $2.73M |
| Other Current Assets | $215.34M |
| Noncurrent Assets | $19.30M |
| Fixed Assets | $2.57M |
| Other Non-current Assets | $16.72M |
| Liabilities | $132.08M |
| Current Liabilities | $68.43M |
| Accounts Payable | $4.74M |
| Wages | $3.23M |
| Other Current Liabilities | $60.47M |
| Noncurrent Liabilities | $63.65M |
| Equity | $105.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $105.28M |
| Liabilities And Equity | $237.36M |
| Net Cash Flow From Operating Activities | -$119.86M |
| Net Cash Flow From Operating Activities, Continuing | -$119.86M |
| Net Cash Flow From Investing Activities | $9.90M |
| Net Cash Flow From Investing Activities, Continuing | $9.90M |
| Net Cash Flow From Financing Activities | $152.03M |
| Net Cash Flow From Financing Activities, Continuing | $152.03M |
| Net Cash Flow | $42.07M |
| Net Cash Flow, Continuing | $42.07M |
| Comprehensive Income/Loss | -$73.97M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$73.97M |
| Other Comprehensive Income/Loss | -$73.97M |